CAR-T Cell Therapy: Discovery, Design, Trials & Patient Care
Published 9/2025
Duration: 1h 16m | .MP4 1280x720 30 fps(r) | AAC, 44100 Hz, 2ch | 641.46 MB
Genre: eLearning | Language: English
Published 9/2025
Duration: 1h 16m | .MP4 1280x720 30 fps(r) | AAC, 44100 Hz, 2ch | 641.46 MB
Genre: eLearning | Language: English
Chimeric Antigen Receptor (CAR) T-cell therapy -Molecular designs to clinical application, for students & researchers
What you'll learn
- Explain the historical development and biological basis of CAR-T therapy.
- Compare and evaluate CAR generations and their clinical performance.
- Identify and manage key toxicities and challenges in CAR-T treatment.
- Understand emerging synthetic biology and solid tumor strategies.
Requirements
- No prior experience is required
- Passion for science and basic scientific foundation will ensure you can engage with the material at a deeper level
Description
Are you ready to master one of the most transformative advances in cancer treatment?
CAR-T (Chimeric Antigen Receptor T-cell) therapyrepresents a groundbreaking fusion of immunology, genetic engineering, and clinical oncology—offering hope for patients with otherwise untreatable cancers. This expertly crafted course,“CAR-T Cell Therapy: From Concept to Clinic,”provides a comprehensive yet concise exploration of CAR-T technology, tailored specifically for advanced medical students, oncology fellows, PhD researchers, and biotech innovators.
In this course, you will embark on a detailed journey starting from thehistorical origins of immunotherapyto the cutting-edge developments insynthetic biology and next-generation CAR designs. Learn how scientists engineered T cells to recognize and destroy cancer cells, bypassing traditional immune system limitations. Gain a deep understanding of CAR-T cell generations, from first-generation constructs to the sophisticated fifth-generation CARs currently in clinical trials.
This course also delivers essential clinical knowledge on themanagement of CAR-T toxicitiessuch ascytokine release syndrome (CRS) and neurotoxicity (ICANS), equipping you with practical insights used by leading oncologists worldwide. Explore how CAR-T therapies have revolutionized treatment for hematological malignancies like B-cell lymphoma and multiple myeloma, and delve into ongoing research tackling the unique challenges posed by solid tumors.
Beyond foundational science, discover the latest advancements, includingdual-targeting CARs, armored T cells, synNotch receptor technology, and orthogonal cytokine systems. These innovations represent the future of personalized cancer immunotherapy and open new therapeutic possibilities.
Whether you are preparing for a clinical rotation in oncology, pursuing cancer immunology research, or working in biotech R&D, this course gives you a strategic edge by synthesizing complex concepts into digestible modules. In around 60 minutes, you will transform your understanding of cellular immunotherapy, empowering you to contribute meaningfully to this dynamic, life-saving field.
Enroll today and join the forefront ofcancer immunotherapy education, unlock the science, clinical applications, and future innovations of CAR-T cell therapy.
Who this course is for:
- Advanced Medical Students & Oncology Fellows seeking real-world clinical context for CAR-T cell therapy.
- PhD Researchers in Immunology & Molecular Biology designing next-gen cellular therapies.
- Biotech & Pharma Professionals entering the field of cancer immunotherapy.
- Academic Faculty & Postdocs needing a compact yet comprehensive CAR-T refresher or curriculum supplement.
More Info